Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial.
about
Where are oncofertility and fertility preservation treatments heading in 2016?The PREgnancy and FERtility (PREFER) study: an Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patients.Current state and controversies in fertility preservation in women with breast cancer.Protecting Effects of Gonadotropin-Releasing Hormone Agonist on Chemotherapy-Induced Ovarian Damage in Premenopausal Breast Cancer Patients: A Systematic Review and Meta-Analysis.The correlation of age with chemotherapy-induced ovarian function failure in breast cancer patients.Investigational and experimental GnRH analogs and associated neurotransmitters.Pharmacotherapy to protect ovarian function and fertility during cancer treatment.Fertility preservation in women with CNS tumors.News on the medical treatment of young women with early-stage HER2-negative breast cancer.Factors associated with ovarian function recovery after chemotherapy for breast cancer: a systematic review and meta-analysis.Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer.Pharmacotherapeutic Targeting of G Protein-Coupled Receptors in Oncology: Examples of Approved Therapies and Emerging Concepts.Rapamycin Prevents cyclophosphamide-induced Over-activation of Primordial Follicle pool through PI3K/Akt/mTOR Signaling Pathway in vivo.Cancer and fertility preservation: international recommendations from an expert meeting.Endocrine prevention of chemotherapy-induced ovarian failure.Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.Fertility Preservation in Female Patients with Breast Cancer - a Current Overview.Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy.Advances in fertility preservation of female patients with hematological malignancies.A gonadotropin-releasing hormone agonist for the prevention of docetaxel-induced gonadal damage.Could gonadotropin-releasing hormone analogs be helpful in the treatment of triple-negative breast cancer?Sequential versus simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: effects on ovarian function, disease-free survival, and overall survivaFertility preservation for patients with breast cancer: The Korean Society for Fertility Preservation clinical guidelines.Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status.Long-term consequences of ovarian ablation for premenopausal breast cancer.A Combination of a GnRH Antagonist and Agonist for Fertility Preservation in an Adolescent Female Murine Model.Gonadotropin-releasing hormone analogs for ovarian function protection during chemotherapy in young early breast cancer patients: the last piece of the puzzle?Controversies in oncology: which adjuvant endocrine therapy is to be given to premenopausal patients with hormone receptor-positive breast cancer?Spotlight on triptorelin in the treatment of premenopausal women with early-stage breast cancer.Glomerular Disease in Women.Fertility preservation for adolescent and young adult cancer patients in Japan
P2860
Q30249457-7894600B-A26A-440B-BF9F-E4A498B56025Q33705941-74F1AFC6-E5EF-443D-8D7F-47E616F4E6A9Q33779879-EE22FBE8-4740-4482-93EA-6C56FD4A6B1AQ36404774-6219B16D-E089-4B8F-91DF-709C56033CCCQ37706917-78E7F303-589A-4DEA-9D98-8D29E9203C93Q38691029-861347A5-7AC3-493B-B49F-8EFE4CD3CE33Q38841994-DBCC4322-B029-4E41-8082-D3F4F2B202A2Q38843979-BC3A57C0-61F4-4EE9-8932-0CA05133ADC0Q38870541-2882311D-5C6E-4506-8280-14C07417D07FQ38963455-CD34C2C7-05E6-42D1-915C-8FCFC52466EEQ38968531-70D88801-693C-4805-B3DC-CF0D892224B3Q39236911-74554B2D-FAEE-4BA4-862C-D2AA7144564BQ41439153-E6DF06F7-E861-41F1-ABBA-35C665E3E8D9Q43106184-A3E0B8E8-E7AD-4B12-B8C2-1F05AD0C36F5Q43958170-0169897A-E2EA-415A-8DA7-28E28A909A94Q46144166-67D6228A-4331-452E-A5FC-49228CFD6AD9Q47139499-204CDCBC-A71C-40B1-BBD3-F19F41B0380FQ47372927-4F56070E-1018-4CCA-90EE-2313801725C9Q47662579-EDA84C4D-AC14-4D23-8A9E-843B927BF41AQ47764300-8F7CBAF6-1B36-4AD2-BA02-3589F75B7B23Q47848539-9555913F-6039-4593-A46F-E2A7F829B30CQ48248647-DA1A9CC6-F451-46C3-81A4-10C485FB7509Q48502529-9099B977-AB7E-48E5-A564-5DE8BDDA1553Q50222801-7191991F-13DA-4C99-BC23-C7E4D463AFC7Q50848449-D2376910-475F-4077-B717-03C90A9E942DQ50947107-09C04727-2D2B-4950-B1F9-C9B1BC640032Q53097641-7AB03409-61C3-4413-94C5-92AC00D5C919Q54974390-D5ECFF67-A8C2-4616-A875-080E6B0F200DQ54976962-FF585FC8-0B47-412D-A2D7-10AAB9EB90B3Q54994281-26A36970-26BF-44C8-8EC4-2F4C1EEDF272Q57091948-13277A5E-E839-493F-B342-64B45A02CA2A
P2860
Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Ovarian Suppression With Tript ...... : A Randomized Clinical Trial.
@en
type
label
Ovarian Suppression With Tript ...... : A Randomized Clinical Trial.
@en
prefLabel
Ovarian Suppression With Tript ...... : A Randomized Clinical Trial.
@en
P2093
P50
P356
P1476
Ovarian Suppression With Tript ...... : A Randomized Clinical Trial.
@en
P2093
Alessia Levaggi
Andrea Michelotti
Carlo Vecchio
Francesca Poggio
GIM Study Group
Mario Roberto Sertoli
Monica Giordano
Ornella Garrone
Sara Giraudi
P304
P356
10.1001/JAMA.2015.17291
P407
P577
2015-12-01T00:00:00Z